Suppr超能文献

地高辛及其主要代谢产物/衍生物在健康人体内的药代动力学。

Pharmacokinetics of digoxin and main metabolites/derivatives in healthy humans.

作者信息

Hinderling P H, Hartmann D

机构信息

Department of Pharmacology, University of Basel, Switzerland.

出版信息

Ther Drug Monit. 1991 Sep;13(5):381-401. doi: 10.1097/00007691-199109000-00001.

Abstract

Three healthy, young male volunteers received doses of 0.6 and 1.2 mg of specifically labelled [3H]digoxin each by intravenous (i.v.) bolus injection and oral (p.o.) administration in accordance with a randomized four-way crossover design. Plasma, urine, and feces samples were taken over an interval of 144 h after drug administration. Total radioactivity and individual radioactivity assignable to digoxin and its metabolites were measured. After i.v. administration, the mean +/- SD recovery of total radioactivity, as percent of dose, was complete, urine 81.3 +/- 2.0% and feces 17.1 +/- 2.8%. The mean recovery of digoxin and that of its metabolites in urine was digoxin 75.6 +/- 3.0%, dihydrodigoxin 2.8 +/- 1.6%, digoxigenin bisdigitoxoside 1.6 +/- 0.1%, and additional metabolites 1.5 +/- 0.3%. Judging from the metabolite data in urine and considering the 5% impurity of the administered dose, metabolism of digoxin appeared to be insignificant after i.v. administration. The total and renal clearances of digoxin were, on average, 193 +/- 25 ml min-1 and 152 +/- 24 ml min-1. The mean steady state volume of distribution was 489 +/- 73 L and the mean residence time 41 +/- 5 h. For the metabolites dihydrodigoxin and digoxigenin bisdigitoxoside the mean residence times were on average 35 +/- 9 h and 53 +/- 11 h; the renal clearances were 79 +/- 13 ml min-1 and 100 +/- 26 ml min-1. After p.o. administration, the mean recovery of total radioactivity, as percent of the dose, was also complete, urine 65.7 +/- 1.98% and feces 31.6 +/- 7.6%. The mean recovery of digoxin and that of its metabolites, as percent of dose, in urine was digoxin 51.5 +/- 11.4%, dihydrodigoxin 4.5 +/- 3.9%, digoxigenin bisdigitoxoside 1.9 +/- 0.1%, polar metabolites 5.5 +/- 3.8%, and additional metabolites 1.3 +/- 0.6%. After p.o., as compared to i.v. administration, larger amounts of all the metabolites were formed in accordance with first pass metabolism/degradation. Maximum mean plasma concentrations of 4.3 +/- 2.5 ng ml-1 and 9.5 +/- 1.1 ng ml-1 for digoxin were observed at 40 +/- 10 min after p.o. administration of 0.6 and 1.2 mg of the drug. The mean absolute bioavailability of digoxin from an aqueous solution was 0.67 +/- 0.14. Renal clearance and mean oral residence time for digoxin were on average 176 +/- 28 ml min-1 and 37 +/- 4 h after p.o. administration.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

三名健康年轻男性志愿者按照随机四交叉设计,通过静脉推注和口服方式分别接受了剂量为0.6毫克和1.2毫克的特异性标记[³H]地高辛。给药后144小时内采集血浆、尿液和粪便样本。测量了总放射性以及可归属于地高辛及其代谢物的个体放射性。静脉给药后,总放射性的平均回收率(以剂量百分比计)为100%,尿液中为81.3±2.0%,粪便中为17.1±2.8%。尿液中地高辛及其代谢物的平均回收率分别为:地高辛75.6±3.0%,二氢地高辛2.8±1.6%,地高辛配基双洋地黄毒糖苷1.6±0.1%,其他代谢物1.5±0.3%。从尿液中的代谢物数据判断,并考虑到给药剂量的5%杂质,静脉给药后地高辛的代谢似乎不显著。地高辛的总清除率和肾清除率平均分别为193±25毫升/分钟和152±24毫升/分钟。平均稳态分布容积为489±73升,平均驻留时间为41±5小时。二氢地高辛和地高辛配基双洋地黄毒糖苷这两种代谢物的平均驻留时间分别为35±9小时和53±11小时;肾清除率分别为79±13毫升/分钟和100±26毫升/分钟。口服给药后,总放射性的平均回收率(以剂量百分比计)也为100%,尿液中为65.7±1.98%,粪便中为31.6±7.6%。尿液中地高辛及其代谢物的平均回收率(以剂量百分比计)分别为:地高辛51.5±11.4%,二氢地高辛4.5±3.9%,地高辛配基双洋地黄毒糖苷1.9±0.1%,极性代谢物5.5±3.8%,其他代谢物1.3±0.6%。口服给药后,与静脉给药相比,由于首过代谢/降解,所有代谢物的生成量都更大。口服0.6毫克和1.2毫克药物后,地高辛的最大平均血浆浓度分别在40±10分钟时观察到,为4.3±2.5纳克/毫升和9.5±1.1纳克/毫升。地高辛从水溶液中的平均绝对生物利用度为0.67±0.14。口服给药后,地高辛肾清除率和平均口服驻留时间平均分别为176±28毫升/分钟和37±4小时。(摘要截短至400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验